Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Leukemia Research
|
September 29, 2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Jonathan A Webster, Raoul Tibes, Larry Morris, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Blood Neoplasia
|
September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML
Andrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Cell Death and Differentiation
|
March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death
Jia Jia, Wenbo Ji, Antoine N Saliba, et al.
Blood Cancer Discovery
|
November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Cancer Research
|
January 8, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia
Husheng Ding, Nicole D Vincelette, Cordelia D McGehee, et al.
Haematologica
|
May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Blood Advances
|
October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Jonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
Leukemia Research
|
September 29, 2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Jonathan A Webster, Raoul Tibes, Larry Morris, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Blood Neoplasia
|
September 15, 2025
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML
Andrew D Zale, Venkata Preetam Sandeep Kaduluri, Jonathan A Webster, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Cell Death and Differentiation
|
March 28, 2024
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death
Jia Jia, Wenbo Ji, Antoine N Saliba, et al.
Blood Cancer Discovery
|
November 15, 2021
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Joshua F Zeidner, Benjamin G Vincent, Anastasia Ivanova, et al.
Cancer Research
|
January 8, 2021
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia
Husheng Ding, Nicole D Vincelette, Cordelia D McGehee, et al.
Haematologica
|
May 8, 2025
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Jonathan A Webster, Madison Reed, Hua-Ling Tsai, et al.
Blood Advances
|
October 20, 2020
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
Jonathan A Webster, Leo Luznik, Hua-Ling Tsai, et al.
Page
of 3